-
-
-
-
-
-
-
Scynexis (SCYX) to Present Positive Interim Data from the Phase 3 FURI Study of Oral Ibrexafungerp
-
-
-
-
-
-
-
SCYNEXIS Announces One-for-Ten Reverse Stock Split
-
727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

